BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38284451)

  • 21. Teenage-Onset Colorectal Cancers in a Digenic Cancer Predisposition Syndrome Provide Clues for the Interaction between Mismatch Repair and Polymerase δ Proofreading Deficiency in Tumorigenesis.
    Schamschula E; Kinzel M; Wernstedt A; Oberhuber K; Gottschling H; Schnaiter S; Friedrichs N; Merkelbach-Bruse S; Zschocke J; Gallon R; Wimmer K
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer.
    Ricker CN; Hanna DL; Peng C; Nguyen NT; Stern MC; Schmit SL; Idos GE; Patel R; Tsai S; Ramirez V; Lin S; Shamasunadara V; Barzi A; Lenz HJ; Figueiredo JC
    Cancer; 2017 Oct; 123(19):3732-3743. PubMed ID: 28640387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A PMS2 non-canonical splicing site variant leads to aberrant splicing in a patient suspected for lynch syndrome.
    Bouras A; Naibo P; Legrand C; Marc'hadour FL; Ruano E; Grand-Masson C; Lefol C; Wang Q
    Fam Cancer; 2023 Jul; 22(3):303-306. PubMed ID: 36445599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of a novel frameshift variant and a known deleterious variant in MMR genes with Lynch syndrome in Chinese families.
    Li J; Ni H; Wang X; Cheng W; Li L; Cheng Y; Liu C; Li Y; Deng A
    World J Surg Oncol; 2024 Jan; 22(1):36. PubMed ID: 38280988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline PMS2 mutation screened by mismatch repair protein immunohistochemistry of colorectal cancer in Japan.
    Sugano K; Nakajima T; Sekine S; Taniguchi H; Saito S; Takahashi M; Ushiama M; Sakamoto H; Yoshida T
    Cancer Sci; 2016 Nov; 107(11):1677-1686. PubMed ID: 27589204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of Metachronous Colorectal Neoplasm after a Segmental Colectomy in Lynch Syndrome Patients According to Mismatch Repair Gene Status.
    Quezada-Diaz FF; Hameed I; von Mueffling A; Salo-Mullen EE; Catalano A; Smith JJ; Weiser MR; Garcia-Aguilar J; Stadler ZK; Guillem JG
    J Am Coll Surg; 2020 Apr; 230(4):669-675. PubMed ID: 32007537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome.
    Pearlman R; Haraldsdottir S; de la Chapelle A; Jonasson JG; Liyanarachchi S; Frankel WL; Rafnar T; Stefansson K; Pritchard CC; Hampel H
    J Med Genet; 2019 Jul; 56(7):462-470. PubMed ID: 30877237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot study of gene mutations associated with Lynch syndrome in Slovak patients with breast cancer.
    Krasničanová L; Saade R; Priščáková P; Gbelcová H; Kaľavská K; Karaba M; Benca J; Mego M; Repiská V
    Klin Onkol; 2023; 36(2):130-134. PubMed ID: 37072247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers.
    Evans DG; Lalloo F; Ryan NA; Bowers N; Green K; Woodward ER; Clancy T; Bolton J; McVey RJ; Wallace AJ; Newton K; Hill J; McMahon R; Crosbie EJ
    J Med Genet; 2022 Apr; 59(4):328-334. PubMed ID: 33452216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exome sequencing in a Swedish family with PMS2 mutation with varying penetrance of colorectal cancer: investigating the presence of genetic risk modifiers in colorectal cancer risk.
    Bryant P; Walton Bernstedt S; Thutkawkorapin J; Backman AS; Lindblom A; Lagerstedt-Robinson K
    Eur J Cancer Prev; 2023 Mar; 32(2):113-118. PubMed ID: 36134613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PMS2 or PMS2CL? Characterization of variants detected in the 3' of the PMS2 gene.
    Bouras A; Lefol C; Ruano E; Grand-Masson C; Wang Q
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23193. PubMed ID: 37534630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A homozygous PMS2 founder mutation with an attenuated constitutional mismatch repair deficiency phenotype.
    Li L; Hamel N; Baker K; McGuffin MJ; Couillard M; Gologan A; Marcus VA; Chodirker B; Chudley A; Stefanovici C; Durandy A; Hegele RA; Feng BJ; Goldgar DE; Zhu J; De Rosa M; Gruber SB; Wimmer K; Young B; Chong G; Tischkowitz MD; Foulkes WD
    J Med Genet; 2015 May; 52(5):348-52. PubMed ID: 25691505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
    Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations Between Mutations in MSH6 and PMS2 and Risk of Surveillance-detected Colorectal Cancer.
    Lamba M; Wakeman C; Ebel R; Hamilton S; Frampton C; Kiesanowski M; Griffiths B; Keating J; Parry S; Chalmers-Watson T
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2768-2774. PubMed ID: 32240831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression.
    Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK
    Am J Surg Pathol; 2015 Aug; 39(8):1114-20. PubMed ID: 25871621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort.
    Rosty C; Clendenning M; Walsh MD; Eriksen SV; Southey MC; Winship IM; Macrae FA; Boussioutas A; Poplawski NK; Parry S; Arnold J; Young JP; Casey G; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Potter JD; DeRycke M; Lindor NM; Thibodeau SN; Baron JA; Win AK; Hopper JL; Jenkins MA; Buchanan DD;
    BMJ Open; 2016 Feb; 6(2):e010293. PubMed ID: 26895986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
    Espenschied CR; LaDuca H; Li S; McFarland R; Gau CL; Hampel H
    J Clin Oncol; 2017 Aug; 35(22):2568-2575. PubMed ID: 28514183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of paired tumor and germline testing in evaluation of patients with Lynch-like syndrome in a large integrated healthcare setting.
    Carwana H; Hoodfar E; Bergoffen J; Li D
    Fam Cancer; 2021 Jul; 20(3):223-230. PubMed ID: 33215268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refining the role of PMS2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants.
    Borràs E; Pineda M; Cadiñanos J; Del Valle J; Brieger A; Hinrichsen I; Cabanillas R; Navarro M; Brunet J; Sanjuan X; Musulen E; van der Klift H; Lázaro C; Plotz G; Blanco I; Capellá G
    J Med Genet; 2013 Aug; 50(8):552-63. PubMed ID: 23709753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients.
    Kiyozumi Y; Matsubayashi H; Horiuchi Y; Higashigawa S; Oishi T; Abe M; Ohnami S; Urakami K; Nagashima T; Kusuhara M; Miyake H; Yamaguchi K
    Cancer Med; 2019 Sep; 8(12):5534-5543. PubMed ID: 31386297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.